Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial
PLOS One · 2025
DOI: 10.1371/journal.pone.0327211 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2025. Verfasst von Marwan El-Deyarbi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Life Style, Hypoglycemic Agents. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Clinical evidence on the protective effects of a balanced diet, exercise, and medication adherence along with intensive glucose-lowering therapies on diabetes progression is lacking, and interventions that are most effective in slowing cardiorenal metabolic complications in patients with diabetes remain unelucidated.
Objective
To determine the effects of long-term multifactorial interventions on clinical outcomes in Emirati patients with diabetes attending ambulatory healthcare clinics.
Methods
We conducted a randomised controlled clinical trial at the Oud Al-Touba Clinic involving 192 participants with diabetes, who were blinded to the intervention and control groups, and followed up for 1 year. At the 3-, 6-, and 9-month visits, the intervention and control groups received multifactorial interventions and standard routine care, respectively. Glycated haemoglobin A1c (HbA1c) levels, estimated glomerular filtration rate (eGFR), blood pressure, electrolyte levels, and cardiovascular events were assessed at study completion.
Results
During a mean follow-up of 11.9 months, 40.4% of the participants in the intervention group (31.6% in the control group) achieved diabetes control (HbA1c < 7%), with a significant mean difference of −0.36% in HbA1c levels between the groups (95% CI: −0.54 – −0.19, P < 0.01). Participants in the multifactorial group achieved a significant mean difference in low-density lipoprotein cholesterol levels (mean difference = −0.14, 95% CI: −0.27–0.001, P < 0.03), and significant adjusted mean difference of eGFR levels difference (3.93 mL/min/1.73 m 2 , 95% CI: 1.27–6.58, P < 0.01) at study completion compared to those in the control group. Moreover, the percentage of participants in the intervention group who met the blood pressure target increased from 38.3% to 51.1%, accompanied with a decrease in serum electrolyte levels, compared to 34.7% to 36.7% in the control group at the end of the follow-up.
Conclusions
Implementing multifactorial interventions by a multidisciplinary team improved several clinical manifestations, including HbA1c, SBP, and eGFR, and decreased cardiovascular risk factors despite the decreased diabetes medication use.
Trial registration
ClinicalTrials.gov NCT04942119
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.
- Department of Pharmacy, Oud Al-Touba Diagnostic and Screening Clinic, Ambulatory Health Services, Abu Dhabi Health Services Co. (SEHA), Al Ain, UAE.
- Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.
- David Geffen School of Medicine at the University of California, Los Angeles, California, United States of America.
- Department of Geriatrics and Extended Care, VA Greater Los Angeles Healthcare System, U.S. Department of Veterans Affairs, Los Angeles, California, United States of America.
- Division of Endocrinology, Oud Al-Touba Diagnostic and Screening Clinic, Ambulatory Health Services, Abu Dhabi Health Services Co. (SEHA), Al Ain, UAE.
ORCID-Profile: Marwan El-Deyarbi, Salahdein Aburuz
Zitieren
APA
El-Deyarbi, M., Ahmed, L., King, J., Adi, Z. S., Al Juboori, A., Mansour, N. A., Al Nuaimi, H., Beiram, R., & Aburuz, S. (2025). Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial. PLOS One. https://doi.org/10.1371/journal.pone.0327211
Vancouver
El-Deyarbi M, Ahmed L, King J, Adi ZS, Al Juboori A, Mansour NA, et al. Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial. PLOS One. 2025. doi:10.1371/journal.pone.0327211
BibTeX
@article{ElDeyarbi2025,
author = {El-Deyarbi, Marwan and Ahmed, Luai and King, Jeffrey and Adi, Zelal S and Al Juboori, Ahmed and Mansour, Nirmin A and Al Nuaimi, Huda and Beiram, Rami and Aburuz, Salahdein},
title = {Impact of multifactorial interventions with medication and lifestyle optimization on patients with type 2 diabetes: A randomised controlled trial},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0327211}
}
EUVIMED